Suppr超能文献

用于检测凝血因子VIII:抗原(VIII:CAg)的微量酶联免疫吸附测定(ELISA)以及凝血因子VIII:抗原固相免疫分离中凝血因子VIII抑制剂的反应性

Reactivity of factor VIII inhibitors in a micro ELISA for factor VIII: CAg and in solid phase immunoisolation of VIII: CAg.

作者信息

Nordfang O, Ezban M, Dinesen B

出版信息

Thromb Haemost. 1985 Jun 24;53(3):346-50.

PMID:3931283
Abstract

Factor VIII coagulant antigen (VIII: CAg) was measured in a sandwich-ELISA. Microplates were used as solid phase and peroxidase conjugated F(ab')2 fragments of IgG isolated from inhibitor plasma was used as label without affinity purification. The capacity of the assay was high and the sensitivity for VIII: CAg was 0.002 U/ml. Using this assay it was possible to measure coagulation inactive VIII: CAg in samples from purification studies. Below 0.05 VIII: CAg U/ml these samples responded in parallel with standard plasma. Seven of 7 inhibitor antibodies tested were able to inhibit binding of peroxidase-conjugate in the VIII: CAg assay, and the inhibitory capacity correlated with coagulation inhibition as measured by the Bethesda method. Using the highest titered antibodies bound to a solid phase, VIII: CAg was isolated and identified in SDS-PAGE as a doublet with a molecular weight of 77-80 kD.

摘要

采用夹心酶联免疫吸附测定法(ELISA)检测凝血因子VIII促凝抗原(VIII: CAg)。以微孔板作为固相,使用从抑制剂血浆中分离的经辣根过氧化物酶缀合的IgG F(ab')2片段作为标记物,未进行亲和纯化。该检测方法的检测能力较高,对VIII: CAg的灵敏度为0.002 U/ml。利用该检测方法能够在纯化研究的样本中检测到无凝血活性的VIII: CAg。在VIII: CAg低于0.05 U/ml时,这些样本与标准血浆呈平行反应。所检测的7种抑制剂抗体中有7种能够在VIII: CAg检测中抑制过氧化物酶缀合物的结合,且抑制能力与采用贝塞斯达法测定的凝血抑制作用相关。使用与固相结合的效价最高的抗体,VIII: CAg在十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)中被分离并鉴定为分子量为77 - 80 kD的双峰。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验